share_log

Piezo Motion, Benson Engineering Join Forces to Provide OEMs with Breakthrough Technology

Piezo Motion, Benson Engineering Join Forces to Provide OEMs with Breakthrough Technology

Piezo Motion 和 Benson Engineering 联手为 OEM 提供突破性技术
GlobeNewswire ·  2022/03/10 21:06

Piezo Motion partners with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the Southern U.S.

Piezo Motion与Benson Engineering合作,为美国南部地区提供负担得起的微型精密电机和运动控制解决方案。

LAKEWOOD RANCH, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Benson Engineering today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. Benson Engineering, founded in 1946, is a family-owned manufacture representative group with offices in Texas and Missouri.

2022年3月10日,佛罗里达州莱克伍德牧场(Global Newswire)--脑科学公司(OTCQB:BRSF)旗下的Via InvestorWire-Piezo Motion公司今天宣布与本森工程公司建立合作伙伴关系。Piezo Motion是自动化技术的开发商和领先制造商。本森工程公司成立于1946年,是一家家族制造代表集团,在德克萨斯州和密苏里州设有办事处。

Benson Engineering works primarily with original equipment manufacturers (OEMs) in Texas, Louisiana, Oklahoma, Arkansas, Kansas, Missouri, Nebraska and Iowa. Piezo Motion's multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor that is designed specifically for OEMs that require ultimate speed, size and accuracy.

Benson Engineering主要与德克萨斯州、路易斯安那州、俄克拉何马州、阿肯色州、堪萨斯州、密苏里州、内布拉斯加州和爱荷华州的原始设备制造商(OEM)合作。Piezo Motion的多面旋转和直线电机采用的技术提供了稳定、精确的电机,该电机是专门为对速度、尺寸和精度要求极高的OEM而设计的。

"We are looking forward to sharing the outstanding Piezo Motion platform with our customer and prospect base, expanding our value proposition with these clients who enjoy and look for next-level upgrades in motion technology," said Alan Hobbs, vice president at Benson Engineering.

本森工程副总裁总裁表示:“我们期待着与我们的客户和潜在客户共享出色的Piezo Motion平台,与那些喜欢并寻求运动技术下一级升级的客户扩大我们的价值主张。”

Piezo Motion motors are used globally for a variety of applications. These include laboratory instruments, biomedicine, optics, semiconductors, nanotechnology industries, and industrial electronic and automotive systems, along with an expanding portfolio of products that combine performance with dramatically lower cost over conventional piezo solutions.

Piezo Motion马达在全球范围内被用于各种应用。这些领域包括实验室仪器、生物医学、光学、半导体、纳米技术行业以及工业电子和汽车系统,以及不断扩大的产品组合,这些产品结合了性能和比传统压电解决方案低得多的成本。

"Our unique, tiny motors provide unparalleled precision and energy efficiencies to the market," said Hassan Kotob, chairman and CEO of Brain Scientific. "Benson Engineering has been in the industry for more than 75 years and has a stellar reputation. We are looking forward to working with them and providing our precision motors to their customer base at an affordable price."

Brain Science董事长兼首席执行官哈桑·科托布表示:“我们独特的微型电机为市场提供了无与伦比的精度和能效。”本森工程公司在该行业已有超过75年的历史,享有极高的声誉。我们期待着与他们合作,以实惠的价格向他们的客户群提供我们的精密电机。“

About Piezo Motion

关于Piezo Motion

Piezo Motion (piezomotion.com), a Brain Scientific company, is a leader in precision motor technology with multimillion-dollar investments in research and development of affordable piezoelectric motors to meet, and exceed, the needs of today's global markets. The company is committed to the development of innovative technology and motion products that enhance functionality in a multitude of applications. The company works with startups, OEMs, research institutions and industrial companies from around the world, empowering the visionaries behind their products.

Brain Science旗下的Piezo Motion(Piezomotion.com)是精密电机技术的领先者,在研发负担得起的压电式电机方面投资数百万美元,以满足并超越当今全球市场的需求。该公司致力于开发创新技术和运动产品,以增强多种应用的功能。该公司与来自世界各地的初创企业、原始设备制造商、研究机构和工业公司合作,为他们产品背后的远见卓识者赋权。

About Brain Scientific

关于脑科学

Brain Scientific (brainscientific.com) is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap and NeuroEEG are smart neurological diagnostic devices that simplify administration, shorten scan time, and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific's corporate strategy, products, or investor relations, please visit brainscientific.com.

Brain Science是一家拥有多项专利和FDA批准产品的医疗技术公司。Brain Science致力于开发下一代解决方案,以推动神经诊断和OEM医疗设备的未来。Brain Science有两个产品线,涵盖神经学和精密运动。NeuroCap和NeuroEEG是智能神经诊断设备,可以简化管理、缩短扫描时间并降低成本。Piezo Motion产品线由超高效紧凑型精密电机组成,将驱动下一代医疗设备。欲了解有关Brain Science公司的公司战略、产品或投资者关系的更多信息,请访问BrainScience网站。

About Benson Engineering

关于本森工程

Benson Engineering (bensonengineering.com) is a third-generation, family-owned, manufacture representative group founded in 1946.  For more than 75 years, the company has strived to bring its customers quality products, outstanding service, and ethical standards beyond expectation.  Benson Engineering's personnel have all been with the company for a minimum of 20 years each giving long-standing expertise and experience in the territory with many OEMs and distributors.

Benson Engineering(bensonEngineering ering.com)是成立于1946年的第三代家族制造代表性集团。75多年来,公司一直致力于为客户提供优质的产品、卓越的服务和超乎预期的道德标准。Benson Engineering的所有人员都在公司工作了至少20年,每个人都拥有在该地区许多原始设备制造商和分销商的长期专业知识和经验。

Forward-Looking Statements

前瞻性陈述

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of EEG products and services and piezo motor technology; (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items; (iii) the company's future financial performance; (iv) the successful integration of Piezo Motion with and into Brain Scientific; and (v) the assumptions underlying or relating to any statement described in points (i), (ii), (iii) or (iv) above. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, over many of which the company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the company's inability to obtain additional financing; the significant length of time and resources associated with the development of products and related insufficient cash flows and resulting illiquidity; the company's inability to expand its business; significant government regulation of medical devices and the healthcare industry; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans or strategies. Some of these and other factors are identified and described in more detail in the company's filings with the SEC. The company does not undertake to update these forward-looking statements.

本新闻稿中包含的任何不描述历史事实的陈述都可能构成前瞻性陈述。前瞻性陈述可能包括但不限于以下陈述:(I)未来业务的管理计划和目标,包括与脑电产品和服务以及压电电机技术的设计、开发和商业化有关的计划或目标;(Ii)收入(包括收入/亏损)、每股收益(包括收益/亏损)、资本支出、股息、资本结构或其他财务项目的预测;(Iii)公司未来的财务表现;(Iv)Piezo Motion与Brain Science的成功整合;以及(V)以上第(I)、(Ii)、(Iii)或(Iv)点所述任何陈述所依据的或与之有关的假设。此类前瞻性陈述不是为了预测或保证实际结果、业绩、事件或情况,也可能无法实现,因为它们是基于公司目前的预测、计划、目标、信念、预期、估计和假设,受许多风险、不确定性和其他影响的影响,其中许多是公司无法控制的。由于这些风险和不确定性,某些事件和情况的实际结果和时间可能与前瞻性陈述中描述的大不相同。可能影响或导致前瞻性陈述不准确或导致实际结果与预期或期望结果大不相同的因素可能包括但不限于, 该公司无法获得更多融资;与开发产品和相关产品相关的时间和资源过长;现金流不足和由此导致的流动性不足;该公司无法扩大其业务;政府对医疗器械和医疗保健行业的监管力度较大;缺乏产品多元化;该公司原材料价格波动;以及未能实施该公司的业务计划或战略。在该公司提交给美国证券交易委员会的文件中,对其中一些因素以及其他一些因素进行了识别和更详细的描述。该公司不承诺更新这些前瞻性陈述。

CONTACTS

触点

INVESTORS
ir@brainscientific.com

投资商
邮箱:ir@brainScience fic.com

MEDIA
pr@brainscientific.com

媒体
电子邮箱:pr@brainScience fic.com

Corporate Communications

企业通信

IBN (InvestorBrandNetwork)
Los Angeles, California
310.299.1717 Office
Editor@InvestorBrandNetwork.com

IBN(InvestorBrandNetwork)
加利福尼亚州洛杉矶
310.299.1717办公室
邮箱:EDITOR@InvestorBrandNetwork.com


译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发